Concepedia

Frank W. Lee

FW

Statistics

Publications

15

Citations

716

H-Index

12

Active since

1988

Affiliations

Millennium Engineering and Integration (United States)(Current)

Bristol-Myers Squibb (United States)

Research Triangle Park Foundation

GlaxoSmithKline (Netherlands)

University of California, San Francisco

Frank W. Lee is an author at Millennium Engineering and Integration (United States) specializing in pharmacology, pharmacokinetics, and medicine.

Publications per year

1988–2010

15

Publications

15

Unique Preclinical Characteristics of GG745, A Potent Dual Inhibitor of 5AR

H. Neal Bramson, David Hermann, Kenneth W. Batchelor et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 150 citations

, , +16

Effective Dosing Regimen of 1-Aminobenzotriazole for Inhibition of Antipyrine Clearance in Rats, Dogs, and Monkeys

Suresh K. Balani, Tong Zhu, Tian J. Yang et al. · Drug Metabolism and Disposition · 2002 · 110 citations

, , +7

EFFECTIVE DOSING REGIMEN OF 1-AMINOBENZOTRIAZOLE FOR INHIBITION OF ANTIPYRINE CLEARANCE IN GUINEA PIGS AND MICE USING SERIAL SAMPLING

Suresh K. Balani, Ping Li, Joanne Nguyen et al. · Drug Metabolism and Disposition · 2004 · 66 citations

, , +13

EVALUATION OF MICRODOSING TO ASSESS PHARMACOKINETIC LINEARITY IN RATS USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY

Suresh K. Balani, N. Nagaraja, Mark G. Qian et al. · Drug Metabolism and Disposition · 2005 · 61 citations

, , +16

P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor

Johnny Yang, Mark Milton, Shaoxia Yu et al. · Drug Metabolism Letters · 2010 · 54 citations

, , +17

1–5 of 15